Sfoglia per Autore
HCV clearance among hemophiliacs and beta-thalassemics
2007-01-01 DI MARCO V; BRONTE F; SICILY GROUP FOR THE STUDY OF THALASSEMIA; CAPRA M; GERARDI; C; MAGGIO A; MALIZIA R; RIZZO M
STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD
2007-01-01 V DI MARCO; F BRONTE; CABIBI D; F; BARBARIA; Z BORSELLINO; G ALAIMO; S CIMINNISI; M CAPRA; A MAGGIO; PL ALMASIO; A CRAXI
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
2008-01-01 DI MARCO, V; CAPRA, M; GAGLIARDOTTO, F; BORSELLINO, Z; CABIBI, D; BARBARIA, F; FERRARO, D; CUCCIA, L; RUFFO, GB; BRONTE, F; DI STEFANO, R; ALMASIO, PL; CRAXI', A
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C
2008-01-01 DI MARCO V; CAPRA M; GAGLIARDOTTO F; BORSELLINO Z; CABIBI D; BARBARIA F; FERRARO D; CUCCIA L; RUFFO GB; BRONTE F; DI STEFANO R; ALMASIO PL; CRAXÌ A
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
2009-01-01 CAMMÀ C; PETTA S; DI MARCO V; BRONTE F; CIMINNISI S; LICATA G; PERALTA S; SIMONE F; MARCHESINI G; CRAXI' A
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis.
2009-01-01 Cammà, C; Cabibbo, G; Bronte, F; Enea, M; Licata, A; Attanasio, M; Andriulli, A; Craxi, A
Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis
2009-01-01 Petta, S; Cammà, C; DI Marco, V; Calvaruso, V; Enea, M; Bronte, F; Butera, G; Cabibi, D; Craxì, A.
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition.
2009-01-01 Di Marco, V; Bronte, F; Cabibi, D; Calvaruso, V; Alaimo, G; Borsellino, Z; Gagliardotto, F; Almasio, PL; Capra, M; Craxì, A
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy
2009-01-01 Calvaruso, V; Cammà, C; Di Marco, V; Maimone, S; Bronte, F; Enea, M; Dardanoni, V; Manousou, P; Pleguezuelo, M; Xirouchakis, E; Attanasio, M; Dusheiko, G; Burroughs, AK; Craxì A
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis
2011-01-01 Di Marco, V; Calvaruso, V; Iacò, A; Bronte, F; Biasi, L; Prestini, K; Sacchi, P; Amaddeo, G; Squadrito, G; Bruno, R; Puoti, M; Craxi, A
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.
2011-01-01 Rizzo, L; Calvaruso, V; Cacopardo, B; Alessi, N; Attanasio, M; Petta, S; Fatuzzo, F; Montineri, A; Mazzola, A; L'abbate, L; Nunnari, G; Bronte, F; Di Marco, V; Craxì, A; Cammà, C.
IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.
2012-01-01 Di Marco, V; Bronte, F; Calvaruso, V; Capra, M; Borsellino, Z; Maggio, A; Renda, MC; Pitrolo, L; Lo Pinto, MC; Rizzo, M; Fiorenza, F; Gerardi, C; Grimaudo, S; Di Cristina, A; Levrero, M; Craxi, A
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C
2012-01-01 Cammà, C; Petta, S; Enea, M; Bruno, R; Bronte, F; Capursi, V; Cicchetti, A; Colombo, GL; Di Marco, V; Gasbarrini, A; Craxì, A
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis
2013-01-01 Calvaruso, V; Bronte, F; Conte, E; Simone, F; Craxi, A; Di Marco, V
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC
2013-01-01 Bronte, F.; Ferraro, D.; Calvaruso, V.; Pecoraro, G.; Sferrazza, S.; Augugliaro, M.; Destri, N.; Craxi, A.; DI MARCO, V.
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene
2014-01-01 Bronte, F.; Pipitone, R.; Grimaudo, S.; Ferraro, D.; Calvaruso, V.; Sferrazza, S.; Pecoraro, G.; Augugliaro, M.; Craxi, A.; DI MARCO, V.
Targeted Therapies in Hepatocellular Carcinoma
2014-01-01 Bronte, F.; Bronte, G.; Cusenza, S.; Fiorentino, E.; Rolfo, C.; Cicero, G.; Bronte, E.; DI MARCO, V.; Firenze, A.; Angarano, G.; Fontana, T.; Russo, A.
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment
2015-01-01 Bronte, E.; Bronte, G.; Novo, G.; Bronte, F.; Bavetta, M.; Re, G.; Brancatelli, G.; Bazan, V.; Natoli, C.; Novo, S.; Russo, A.
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis
2015-01-01 Calvaruso V, Di Marco V, Bavetta MG, Cabibi D, Conte E, Bronte F, Simone F, Burroughs AK, Craxì A.
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy
2015-01-01 Bronte, G; Bronte, E; Novo, G; Pernice, G; Lo Vullo, F; Musso, E; Bronte, F; Gulotta, E; Rizzo, S; Rolfo, C; Silvestris, N; Bazan, V; Novo, S; Russo, A
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile